The US Food and Drug
Administration (FDA) has announced meeting to update and discuss the new version
of the eCTD Module 1 document. The purpose of this meeting is to provide
clarification and answer questions from industry and software vendors regarding
the changes being made to the module 1 by FDA.
Date
and Time of meeting: 18th September 2012 (Tuesday) from 8 a.m. to
11:30 a.m.
Location:
FDA
White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, Great Room 1503, Silver Spring, MD,
20993.
Registration
Limit: only 350.
Registration
Process: Need to send registration
information including name, title, firm name, address, telephone, and fax number
to Julie Quinonez.
Contact
Information: Julie
Quinonez,
Center
for Drug Evaluation and Research, Food and Drug
Administration,
10903 New Hampshire Ave., Bldg. 22, rm. 1135,
Silver
Spring, MD, 20993,
301-796-0282, FAX: 301-796-9876,
email: Julie.Quinonez@fda.hhs.gov
No comments:
Post a Comment